Cronos (CRON) Cash from Investing Activities (2019 - 2026)
Cronos (CRON) posted quarterly Cash from Investing Activities of $38.0 million for Q1 2026, up 168.7% year-over-year from $14.2 million in Q1 2025, and up 1266.97% quarter-over-quarter from $2.8 million in Q4 2025.
Cronos (CRON) Cash from Investing Activities (2019 - 2026) Analysis & Trends
Cronos' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $38.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 168.7% year-over-year to $38.0 million; the TTM figure through Mar 2026 stood at $16.8 million (up 124.12% YoY), while the FY2025 annual figure was -$76.6 million, down 143.71% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $38.0 million, up from $2.8 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $189.6 million in Q1 2024, with the low at -$303.8 million in Q1 2023.
- The 5-year median for Cash from Investing Activities is -$818000.0 (2024), against an average of $4.4 million.
- Peak annual rise in Cash from Investing Activities reached 231.33% in 2023, while the deepest fall reached 303912.0% in 2023.
- Cronos' Cash from Investing Activities stood at $158.5 million in 2022, then tumbled by 48.32% to $81.9 million in 2023, then plunged by 106.14% to -$5.0 million in 2024, then surged by 155.29% to $2.8 million in 2025, then jumped by 1266.97% to $38.0 million in 2026.
- Business Quant data shows CRON's Cash from Investing Activities at $38.0 million in Q1 2026, $2.8 million in Q4 2025, and -$23.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | -358.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -358.30 Mn |
| Jun 30, 2026 | -358.30 Mn |
| Mar 31, 2026 | 38.03 Mn |
| Mar 31, 2026 | 38.03 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | -23.00 Mn |
| Sep 30, 2025 | -23.00 Mn |
| Jun 30, 2025 | -983,000.00 |
| Jun 30, 2025 | -983,000.00 |
| Mar 31, 2025 | -55.36 Mn |
| Mar 31, 2025 | -55.36 Mn |
| Dec 31, 2024 | -5.03 Mn |
| Dec 31, 2024 | -5.03 Mn |
| Sep 30, 2024 | -818,000.00 |
| Sep 30, 2024 | -818,000.00 |
| Jun 30, 2024 | -8.56 Mn |
| Jun 30, 2024 | -8.56 Mn |
| Mar 31, 2024 | 189.56 Mn |
| Mar 31, 2024 | 189.56 Mn |